Literature DB >> 16454559

BRCA1 and BRCA2 mutation screening using SmartCycler II high-resolution melt curve analysis.

Scott D Dufresne1, Dorothy R Belloni, Wendy A Wells, Gregory J Tsongalis.   

Abstract

CONTEXT: Real-time polymerase chain reaction technologies have replaced many of the more labor-intense methods in the molecular diagnostics laboratory. Similarly, melt curve analysis can provide a rapid means of mutation screening.
OBJECTIVE: To determine if real-time polymerase chain reaction and melt curve analysis using the SmartCycler II could be used as a screening tool for 3 common mutations in BRCA1 and BRCA2.
DESIGN: Real-time polymerase chain reaction amplification with SYBR Green I detection was performed on DNA from cell lines known to carry the 185delAG or 5382insC mutation in BRCA1 or the 6174delT mutation in BRCA2. The melting temperatures and the melt curves were analyzed for differences between wild-type DNA and cell lines that were heterozygous for each mutation.
RESULTS: Significant differences were present in the melt curves for each of the mutations compared with those of the wild-type sequences. The melt curve for the 185delAG mutation showed a separate peak at a lower temperature, which represented the melting temperature of the heteroduplex. For the 6174delT mutation, the melt curve had a shoulder at a lower temperature, while the melt curve for the 5382insC mutation was shifted to the left and was broader than that for the wild-type sequences.
CONCLUSIONS: High-resolution melt curve analysis is a quick, reliable method for identifying mutations due to small deletions or insertions. As a proof of principle, we used this assay to identify the 3 most common BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16454559     DOI: 10.5858/2006-130-185-BABMSU

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  7 in total

1.  High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families.

Authors:  Aouatef Riahi; Maher Kharrat; Imen Lariani; Habiba Chaabouni-Bouhamed
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

2.  A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes.

Authors:  Heather L Hondow; Stephen B Fox; Gillian Mitchell; Rodney J Scott; Victoria Beshay; Stephen Q Wong; Alexander Dobrovic
Journal:  BMC Cancer       Date:  2011-06-24       Impact factor: 4.430

3.  Screening of exon 11 of BRCA1 gene using the high resolution melting approach for diagnosis in Moroccan breast cancer patients.

Authors:  Meryam El Khachibi; Brehima Diakite; Khalil Hamzi; Abdallah Badou; Mohamed Amine Senhaji; Amina Bakhchane; Hassan Jouhadi; Abdelhamid Barakat; Abdellatif Benider; Sellama Nadifi
Journal:  BMC Cancer       Date:  2015-02-25       Impact factor: 4.430

4.  Genome sequencing and CRISPR/Cas9 gene editing of an early flowering Mini-Citrus (Fortunella hindsii).

Authors:  Chenqiao Zhu; Xiongjie Zheng; Yue Huang; Junli Ye; Peng Chen; Chenglei Zhang; Fei Zhao; Zongzhou Xie; Siqi Zhang; Nan Wang; Hang Li; Lun Wang; Xiaomei Tang; Lijun Chai; Qiang Xu; Xiuxin Deng
Journal:  Plant Biotechnol J       Date:  2019-05-21       Impact factor: 9.803

5.  Detection and identification of old world Leishmania by high resolution melt analysis.

Authors:  Dalit Talmi-Frank; Abedelmajeed Nasereddin; Lionel F Schnur; Gabriele Schönian; Seray Ozensoy Töz; Charles L Jaffe; Gad Baneth
Journal:  PLoS Negl Trop Dis       Date:  2010-01-12

6.  Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis.

Authors:  Elena A Takano; Gillian Mitchell; Stephen B Fox; Alexander Dobrovic
Journal:  BMC Cancer       Date:  2008-02-25       Impact factor: 4.430

7.  Gateway-Compatible CRISPR-Cas9 Vectors and a Rapid Detection by High-Resolution Melting Curve Analysis.

Authors:  Cynthia J Denbow; Samantha Lapins; Nick Dietz; Raelynn Scherer; Zachary L Nimchuk; Sakiko Okumoto
Journal:  Front Plant Sci       Date:  2017-07-05       Impact factor: 5.753

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.